Cargando...

Monoclonal antibodies and Fc fragments for treating solid tumors

Advances in biotechnology, better understanding of pathophysiological processes, as well as the identification of an increasing number of molecular markers have facilitated the use of monoclonal antibodies and Fc fragments in various fields in medicine. In this context, a rapidly growing number of t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Eisenbeis, Andrea M, Grau, Stefan J
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3266862/
https://ncbi.nlm.nih.gov/pubmed/22291463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S19955
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!